A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Public ClinicalTrials.gov record NCT03085095. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
HERO: A Multinational Phase 3 Randomized, Open-label, Parallel Group Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine the efficacy and safety of relugolix 120 milligrams (mg) orally once daily for 48 weeks on maintaining serum testosterone suppression to castrate levels (\< 50 nanograms/deciliter \[ng/dL\]) in participants with androgen-sensitive advanced prostate cancer.
Study identification
- NCT ID
- NCT03085095
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,134 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 18, 2017 (Actual)
- Primary completion
- Oct 25, 2019 (Actual)
- Completion
- Nov 26, 2021 (Actual)
- Last update posted
- Jan 18, 2022
2017 – 2021
United States locations
- U.S. sites
- 27
- U.S. states
- 21
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Tucson | Tucson | Arizona | 85741 | — |
| Orange | Orange | California | 92868 | — |
| Denver | Denver | Colorado | 80211 | — |
| Pompano Beach | Pompano Beach | Florida | 33060 | — |
| Jeffersonville | Jeffersonville | Indiana | 47130 | — |
| Des Moines | Des Moines | Iowa | 50266 | — |
| Wichita | Wichita | Kansas | 67226 | — |
| Baltimore | Baltimore | Maryland | 21204 | — |
| Troy | Troy | Michigan | 48084 | — |
| Omaha | Omaha | Nebraska | 68130 | — |
| Las Vegas | Las Vegas | Nevada | 89135 | — |
| Brick | Brick | New Jersey | 08724 | — |
| Albuquerque | Albuquerque | New Mexico | 87109 | — |
| Albany | Albany | New York | 12208 | — |
| Garden City | Garden City | New York | 11530 | — |
| Plainview | Plainview | New York | 11803 | — |
| Poughkeepsie | Poughkeepsie | New York | 12601 | — |
| Syracuse | Syracuse | New York | 13210 | — |
| Durham | Durham | North Carolina | 27710 | — |
| Greensboro | Greensboro | North Carolina | 27403 | — |
| Cincinnati | Cincinnati | Ohio | 45212 | — |
| Middleburg Heights | Middleburg Heights | Ohio | 44130 | — |
| Oklahoma City | Oklahoma City | Oklahoma | 73104 | — |
| Lancaster | Lancaster | Pennsylvania | 17604 | — |
| Myrtle Beach | Myrtle Beach | South Carolina | 29572 | — |
| Nashville | Nashville | Tennessee | 37209 | — |
| San Antonio | San Antonio | Texas | 78258 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 135 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03085095, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 18, 2022 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03085095 live on ClinicalTrials.gov.